Friederike L. Rawert

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 30, 2026

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 19, 2026

SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.

SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 12, 2025

Pelvic Exenteration for Recurrent Vulvar Cancer: A Retrospective Study.

Pelvic Exenteration for Recurrent Vulvar Cancer: A Retrospective Study.

Journal: Cancers

Published: December 19, 2023

Pelvic Exenteration for Recurrent Endometrial Cancer: A 15-Year Monocentric Retrospective Study.

Pelvic Exenteration for Recurrent Endometrial Cancer: A 15-Year Monocentric Retrospective Study.

Journal: Cancers

Published: August 03, 2023

The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.

The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.

Journal: Archives of gynecology and obstetrics

Published: January 27, 2022

Opportunities and Limitations of Pelvic Exenteration Surgery.

Opportunities and Limitations of Pelvic Exenteration Surgery.

Journal: Cancers

Published: October 11, 2021

Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer.

Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer.

Journal: Anticancer research

Published: August 24, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026